Current status of Credé prophylaxis

Related Experiment Video

Updated: Oct 16, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

J M Novak

    American Journal of Optometry and Physiological Optics
    |May 1, 1984
    PubMed

    Insights

    Silver nitrate and antibiotic eye drops are compared for preventing ophthalmia neonatorum. Neither fully prevents infections, highlighting the need for prenatal screening and postpartum observation to protect newborns.

    Area of Science:

    • Neonatal ophthalmology
    • Infectious disease prevention

    Background:

    • Ophthalmia neonatorum is a serious concern in newborns.
    • Traditional prophylaxis includes silver nitrate, with antibiotics also used.

    Purpose of the Study:

    • To compare the efficacy, side effects, and practicality of silver nitrate versus antibiotics for preventing ophthalmia neonatorum.
    • To identify limitations of current prophylactic agents against specific neonatal conjunctivitis pathogens.

    Main Methods:

    • Comparative analysis of silver nitrate and antibiotic prophylaxis.
    • Evaluation of effectiveness against various pathogens causing neonatal conjunctivitis.
    • Consideration of clinical practicality and side effect profiles.

    Main Results:

    • Prophylactic agents, including silver nitrate and antibiotics, show limitations in inhibiting all causative pathogens of ophthalmia neonatorum.
    • Side effects and clinical practicality are key considerations in choosing a prophylactic method.

    Conclusions:

    • Neither silver nitrate nor antibiotics provide complete protection against ophthalmia neonatorum.
    • Complementary strategies like prenatal screening for venereal diseases and vigilant postpartum observation are crucial for reducing incidence.

    More Related Videos

    Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay11:41

    Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

    Published on: March 10, 2015

    Detection of Rabies IgG and IgM Antibodies Using the Rabies Indirect Fluorescent Antibody Test07:54

    Detection of Rabies IgG and IgM Antibodies Using the Rabies Indirect Fluorescent Antibody Test

    Published on: January 19, 2024

    Related Concept Videos

    Standard Precaution01:26

    Standard Precaution

    Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
    Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
    Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

    Transmission-based Precautions I: Contact, Enteric, and Droplets

    Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
    Contact Precautions:
    Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
    Drug Dosage Regimen: Overview01:15

    Drug Dosage Regimen: Overview

    A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
    Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
    Drug Administration and Therapy Phases: Overview01:26

    Drug Administration and Therapy Phases: Overview

    Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
    The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
    The pharmacokinetic phase...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...